Yesterday I watched NBY early but couldn't understand why such news would be ignored. They kept dropping the offer and it finally traded. But today's news was a different story with strong volume and the gap.
I suffer with dry eye problems and its no fun. Not sure if this new "dry eye" drug would benefit me but right now there is nothing but eye drops or lubricants available. Could be a 500 million $ market.
Not aware of the $ value of "flesh eating bacteria" market but like Ebola what it lacks in volume it makes up in sensationalism.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.